Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50480
Title: | Low density lipoprotein control in patients with ischaemic heart disease |
Authors: | Curtolo, Elisa Wirth, Francesca Xuereb, Robert G. Camilleri, Liberato Cignarella, Andrea Azzopardi, Lilian M. |
Keywords: | Coronary heart disease -- Patients Low density lipoproteins -- Metabolism Statins (Cardiovascular agents) Drugs -- Prescribing Coronary heart disease -- Case studies |
Issue Date: | 2018-10 |
Publisher: | University of Malta. Department of Pharmacy |
Citation: | Curtolo, E., Wirth, F., Xuereb, R. G., Camilleri, L., Cignarella, A., & Serracino-Inglott, A. (2018, October). Low density lipoprotein control in patients with ischaemic heart disease. Poster session presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, Washington, USA. |
Abstract: | A poster presentation regarding low density lipoprotein control in patients with ischaemic heart disease. Introduction: The 2013 ACC/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk recommend use of the appropriate intensity of statin and not a specific low density lipoprotein cholesterol (LDL-C) target. The 2016 ESC/EAS guidelines for the management of dyslipidaemias recommend a target LDL-C goal of <1.8 mmol/L or at least 50% relative reduction. Patients with hyperlipidaemia are reported to be undertreated and not attaining recommended LDL-C goals. Aims: To assess LDL-C control and statin prescribing in patients with ischaemic heart disease (IHD) according to the European guidelines. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/50480 |
Appears in Collections: | Scholarly Works - FacM&SPha Scholarly Works - FacSciSOR |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Low_density_lipoprotein_control_in_patients_with_ischaemic_heart_disease_2018.pdf | 316.97 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.